SIONNA THERAPEUTICS, INC. Investment Income, Interest
SIONNA THERAPEUTICS, INC. (SION) reported Investment Income, Interest of $2.59 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- SIONNA THERAPEUTICS, INC. investment income, interest for the quarter ending 2026-06-30 was $2.59M, a 29.45% decline year-over-year.
- SIONNA THERAPEUTICS, INC. investment income, interest for the quarter ending 2026-03-31 was $2.82M, a 6.00% decline year-over-year.
- SIONNA THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-12-31 was $3.17M, a 49.69% increase year-over-year.
- SIONNA THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-09-30 was $3.46M, a 46.88% increase year-over-year.
- SIONNA THERAPEUTICS, INC. investment income, interest for fiscal 2025 was $13.29M, a 62.73% increase from fiscal 2024.
- SIONNA THERAPEUTICS, INC. investment income, interest for fiscal 2024 was $8.17M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.59M 10-Q · filed 2026-08-06 | $5.41M 10-Q · filed 2026-08-06 | $8.58M derived: sum of 3 quarters · filed 2026-08-06 | $12.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.82M 10-Q · filed 2026-05-12 | $5.99M derived: sum of 2 quarters · filed 2026-05-12 | $9.45M derived: sum of 3 quarters · filed 2026-05-12 | $13.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $6.63M derived: sum of 2 quarters · filed 2026-03-02 | $10.29M derived: sum of 3 quarters · filed 2026-08-06 | $13.29M 10-K · filed 2026-03-02 |
| 2025-09-30 | $3.46M 10-Q · filed 2025-11-05 | $7.12M derived: sum of 2 quarters · filed 2026-08-06 | $10.12M 10-Q · filed 2025-11-05 | $12.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.67M 10-Q · filed 2026-08-06 | $6.67M 10-Q · filed 2026-08-06 | $8.79M derived: sum of 3 quarters · filed 2026-08-06 | $11.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.00M 10-Q · filed 2026-05-12 | $5.12M derived: sum of 2 quarters · filed 2026-05-12 | $7.47M derived: sum of 3 quarters · filed 2026-05-12 | $10.04M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $4.47M derived: sum of 2 quarters · filed 2026-03-02 | $7.04M derived: sum of 3 quarters · filed 2026-03-02 | $8.17M 10-K · filed 2026-03-02 |
| 2024-09-30 | $2.35M 10-Q · filed 2025-11-05 | $4.92M derived: sum of 2 quarters · filed 2025-11-05 | $6.05M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $2.57M 10-Q · filed 2025-08-11 | $3.70M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $1.13M 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |